439 studies found for:
lupus
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
|
||||
| 22 | Unknown † |
Lupus Genetics Studies
|
||||
| 23 | Completed |
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis
|
||||
| 24 | Completed |
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
|
||||
| 25 | Completed |
Anti-CD20 in Systemic Lupus Erythematosus
|
||||
| 26 | Completed |
Study of Methotrexate in Lupus Erythematosus
|
||||
| 27 | Unknown † |
Duke Lupus Registry
|
||||
| 28 | Terminated |
A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus
|
||||
| 29 | Recruiting |
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
|
||||
| 30 | Active, not recruiting |
WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)
|
||||
| 31 | Completed |
Balancing Lupus Experiences With Stress Strategies
|
||||
| 32 | Unknown † |
The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
|
||||
| 33 | Completed |
Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
|
||||
| 34 | Not yet recruiting |
Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
|
||||
| 35 | Completed |
Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis
|
||||
| 36 | Unknown † |
Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
|
||||
| 37 | Completed |
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
|
||||
| 38 | Withdrawn |
Velcade for Proliferative Lupus Nephritis
|
||||
| 39 | Recruiting |
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
|
||||
| 40 | Terminated |
Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
|
† Indicates status has not been verified in more than two years

